Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells - Wikidata - wikimedia - TriplyDB

Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells

Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells

http://www.wikidata.org/entity/Q24319998

about

Membrane attack by complement: the assembly and biology of terminal complement complexes Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy Response gene to complement 32 regulates the G2/M phase checkpoint during renal tubular epithelial cell repair.Response gene to complement 32 protein promotes macrophage phagocytosis via activation of protein kinase C pathway.Upregulation of the cell-cycle regulator RGC-32 in Epstein-Barr virus-immortalized cells.Correlation analysis connects cancer subtypes.RGC32 deficiency protects against high-fat diet-induced obesity and insulin resistance in mice.Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration.RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.Response gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4.Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice.RGC-32 is a novel regulator of the T-lymphocyte cell cycle Sublytic C5b-9 triggers glomerular mesangial cell apoptosis via XAF1 gene activation mediated by p300-dependent IRF-1 acetylation.Complement in atherosclerosis: friend or foe?Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.The role of complement activation in atherogenesis: the first 40 years.Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration.The role of complement system in adipose tissue-related inflammation.Epigenetic modifications induced by RGC-32 in colon cancer.C5b-9-activated, K(v)1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation.Regulator of Cell Cycle (RGCC) Expression During the Progression of Alzheimer's Disease.Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32.The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis.RGC-32 Promotes Th17 Cell Differentiation and Enhances Experimental Autoimmune Encephalomyelitis.RGC-32 (Response Gene to Complement 32 Protein) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis.Response gene to complement 32 suppresses adipose tissue thermogenic genes through inhibiting β3-adrenergic receptor/mTORC1 signaling.Gene expression analysis of human adipose tissue-derived stem cells during the initial steps of in vitro osteogenesis.Renal proteomic analysis of RGC-32 knockout mice reveals the potential mechanism of RGC-32 in regulating cell cycle.Expression of response gene to complement-32 in renal tissue of children with immunoglobulin A nephropathy.Response Gene to Complement 32 in Vascular Diseases

P2860

93bb31d4fb5c328fad48528c6bed7bb242a80111 9e06d7974f568b2d3c1eb7d655d7147878f4252f b808c03fa838537b2c409d6756b98703681e2b4d

P248

Q26997385-9BE13CF2-BDF8-4434-B047-D740B31084EF Q27027097-753B791F-69EB-4179-908D-5062288A0955 Q33634561-ACB14323-9E39-4E06-8D26-1E8D0750F5CA Q34044591-52562795-458F-4AFE-AF37-8685A54A826B Q34097970-30B8946E-4615-4923-A50D-01499C75FDD3 Q34828696-AD321418-DA03-45A2-9C8E-62AEDE9B59C7 Q34944257-62A318DE-8FD5-4235-B78B-2BDB28CD090C Q35135052-22688AEC-FF70-4611-A67C-2C00481C01F5 Q35953156-340CB196-F3AE-4D97-B329-F109876455E7 Q36473183-7088DBF0-6F7A-4E3A-8039-48AF6535650A Q37104156-DCFE2230-BD53-4DE7-8BA8-7BFAB812B056 Q37334611-8DA95EA1-9B64-4104-909A-92789ABC47EF Q37726137-021BCE4A-B99E-473A-B884-90AD6DD78EBE Q37820714-D7AEE6D2-1B6F-44F1-BE3F-200AFFB35DC5 Q38068141-246FB75E-38AD-4B16-9BA1-587AF30C55C1 Q38532361-2DF795E4-5ABB-4D56-BBA8-5F173BE3ADE9 Q38543289-0489AAE3-D2D7-4EE7-BEB4-476F36A501F7 Q38692815-9D8080E9-8EB4-4685-94A0-E4D937AA3D29 Q39780293-822AE584-3154-48A2-83E8-2F9C74BFF1A6 Q42829214-FF4A4E78-7A30-45B1-B515-F0C4FEBEFA95 Q43266310-EA17B947-E01B-48FF-A700-87DAE7869342 Q47547593-036F4D1C-BE0D-4F02-8C9E-07BE1E310CFA Q47715259-D99D1FCB-CA17-4E4B-947D-9B215A4FBB47 Q47930819-AECE215F-EF64-4554-83CB-789A750531C0 Q49960681-BC2235CC-B09B-4821-AC8F-9A859AA8345C Q52341640-719633D7-7A4E-48E3-9F00-C5649F1247B7 Q52651232-A3C35A8F-77C2-41CF-92E5-2371EF1E1052 Q52720151-A70E2EF1-22D2-4D82-A3B7-AD993A068CDD Q53240171-1286892A-340E-40F3-9A17-52FD668098D3 Q57073642-DA33CB42-A00F-4B24-9477-0C05442BE108

P2860

Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells

http://www.wikidata.org/entity/Q24319998

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Response gene to complement 32 ...... ctivation in endothelial cells

@ast

Response gene to complement 32 ...... ctivation in endothelial cells

@en

Response gene to complement 32 ...... ctivation in endothelial cells

@en-gb

Response gene to complement 32 ...... ctivation in endothelial cells

@nl

type

label

Response gene to complement 32 ...... ctivation in endothelial cells

@ast

Response gene to complement 32 ...... ctivation in endothelial cells

@en

Response gene to complement 32 ...... ctivation in endothelial cells

@en-gb

Response gene to complement 32 ...... ctivation in endothelial cells

@nl

prefLabel

Response gene to complement 32 ...... ctivation in endothelial cells

@ast

Response gene to complement 32 ...... ctivation in endothelial cells

@en

Response gene to complement 32 ...... ctivation in endothelial cells

@en-gb

Response gene to complement 32 ...... ctivation in endothelial cells

@nl

P1433

Q24319998-89471CB8-EC3E-43A3-9FEF-561F9088A0D9

P1476

Q24319998-AAB21F18-E8C1-4E2B-BF21-AB1A67FD42DE

P2093

Q24319998-5A84EC46-6282-4EB1-9EF4-EAFCD4D3300B

Q24319998-782841FF-5CED-43EB-BE05-25F00AF13A67

Q24319998-7A4A26AF-C21E-48AD-9045-A63D9E2A9456

Q24319998-846A9382-45F2-4696-9DE1-AB949758B749

Q24319998-94A849A3-ABFE-42BB-A974-5671F3459DDF

Q24319998-9B301622-B7C8-48F6-9E10-D1C091F9A0CF

Q24319998-9E881B20-9601-4A6E-80D7-FE451011B21A

Q24319998-B27A9798-82D7-4E46-B6DA-F46B4E6B3E34

Q24319998-D105ECDE-B0C6-40C3-AB04-49905CDEB4AF

P2860

Q24319998-02BF7981-513E-4920-840F-D284FCCA64B5

Q24319998-0775CC23-D3B8-4E93-B07D-6E97CAEB7504

Q24319998-0DF4D594-D657-4794-9B88-E8E0EFE6DE2A

Q24319998-129F6D31-9643-43EC-83F0-2011C5657FD0

Q24319998-13D0EE22-FB10-46D8-8C81-57962A02C7D7

Q24319998-176CE969-590A-4167-9DFE-465C9B2F9874

Q24319998-2466769C-ACA9-4B72-BB7C-7F63BBE8E8EA

Q24319998-26ACAA16-19B3-45C1-B92F-A7513D293469

Q24319998-26D0905C-AFAD-4E77-98F9-8F6E8B14FDD3

Q24319998-3B0F9B06-CDE0-4E26-BA72-EC42B0625BF5

P304

Q24319998-D269ACC2-B4AF-4FA3-864F-D3AB490947F4

P31

Q24319998-BF1FEF83-FDEA-485F-9E5C-2297A880C41C

P356

Q24319998-8806F3C8-BB9C-4837-B771-7E98D5AAE24F

P407

Q24319998-E6B5A6E1-D7AA-4C0E-9829-DA8446372783

P433

Q24319998-8E20FB00-B66D-4845-821A-0019CACA7274

P478

Q24319998-991115E6-8596-43E1-B11E-621DF7783DF6

P577

Q24319998-3580CF4D-0609-4B64-835E-3021E0B9379D

P5875

Q24319998-A0C42CD9-46D3-4C78-95C9-F97CD6D8E8A3

P698

Q24319998-F2A757C8-D03C-49A3-A2AB-26008044A411

P921

Q24319998-1A5BD332-C530-453B-84CB-B3FD2ACFACCF

Q24319998-3B467133-EED5-457A-A27D-96AA115DB245

Q24319998-58A6C08A-1F4E-424F-B380-C82167F6ECB4

Q24319998-F396D447-C93F-44CE-AEC6-C1ECFF021EC1

P932

Q24319998-3C3F543C-E083-4F4E-ABC8-40AF4A2382BA

P356

J.YEXMP.2008.12.005

P1433

Experimental and Molecular Pathology

P1476

Response gene to complement 32 ...... ctivation in endothelial cells

@en

P2093

Cornelia Cudrici

http://www.w3.org/2001/XMLSchema#string

Cosmin A Tegla

http://www.w3.org/2001/XMLSchema#string

Florin Niculescu

http://www.w3.org/2001/XMLSchema#string

Horea Rus

http://www.w3.org/2001/XMLSchema#string

Kateryna Soloviova

http://www.w3.org/2001/XMLSchema#string

Matthew Fosbrink

http://www.w3.org/2001/XMLSchema#string

Sonia Vlaicu

http://www.w3.org/2001/XMLSchema#string

Takahiro Ito

http://www.w3.org/2001/XMLSchema#string

Violeta Rus

http://www.w3.org/2001/XMLSchema#string

P2860

RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase

cdc2 family kinases phosphorylate a human cell DNA replication factor, RPA, and activate DNA replication

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

CDK inhibitors: positive and negative regulators of G1-phase progression

Vascular endothelium and atherosclerosis

Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic

Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation

Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes

Overexpression of RGC-32 in colon cancer and other tumors.

Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells.

P304

87-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YEXMP.2008.12.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23931173

http://www.w3.org/2001/XMLSchema#string

P698

19162005

http://www.w3.org/2001/XMLSchema#string

P921

positive regulation of G1/S transition of mitotic cell cycle

Regulator of cell cycle

clinical chemistry

P932

2699899

http://www.w3.org/2001/XMLSchema#string